Steven Cohen's IDYA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 327,901 shares of IDEAYA Biosciences, Inc. (IDYA) worth $10.93 M, representing 0.01% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in IDYA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 4.89 M shares. Largest reduction occurred in Q4 2025, reducing 1.97 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's IDEAYA Biosciences (IDYA) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEAYA Biosciences (IDYA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1.52 M | Reduce 82.22% | 327,901 | $33.32 |
| Q4 2025 | -1.97 M | Reduce 51.66% | 1.84 M | $34.57 |
| Q3 2025 | -1.21 M | Reduce 24.12% | 3.82 M | $27.21 |
| Q2 2025 | +4.89 M | Add 3488.42% | 5.03 M | $21.02 |
| Q1 2025 | +140,125 | New Buy | 140,125 | $16.38 |
| Q2 2023 | -5,265 | Sold Out | 0 | $0.00 |
| Q1 2023 | +2,584 | Add 96.38% | 5,265 | $13.73 |
| Q4 2022 | +2,681 | New Buy | 2,681 | $18.17 |
| Q3 2022 | -1.51 M | Sold Out | 0 | $0.00 |
| Q2 2022 | -338,017 | Reduce 18.30% | 1.51 M | $13.80 |
| Q1 2022 | +496,617 | Add 36.78% | 1.85 M | $11.19 |
| Q4 2021 | +367,200 | Add 37.35% | 1.35 M | $23.64 |
| Q3 2021 | +293,255 | Add 42.50% | 983,200 | $25.49 |
| Q2 2021 | -143,755 | Reduce 17.24% | 689,945 | $20.99 |
| Q1 2021 | -277,411 | Reduce 24.97% | 833,700 | $23.50 |
| Q4 2020 | -45,553 | Reduce 3.94% | 1.11 M | $14.00 |
| Q3 2020 | +147,400 | Add 14.60% | 1.16 M | $12.56 |
| Q2 2020 | +811,649 | Add 410.72% | 1.01 M | $14.21 |
| Q3 2019 | +2,048 | Add 1.05% | 197,615 | $9.00 |
| Q2 2019 | +195,567 | New Buy | 195,567 | $9.96 |
Steven Cohen's IDEAYA Biosciences Investment FAQs
Steven Cohen first purchased IDEAYA Biosciences, Inc. (IDYA) in Q2 2019, acquiring 195,567 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held IDEAYA Biosciences, Inc. (IDYA) for 22 quarters since Q2 2019.
Steven Cohen's largest addition to IDEAYA Biosciences, Inc. (IDYA) was in Q2 2025, adding 5,028,279 shares worth $105.69 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 327,901 shares of IDEAYA Biosciences, Inc. (IDYA), valued at approximately $10.93 M.
As of the Q1 2026 filing, IDEAYA Biosciences, Inc. (IDYA) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in IDEAYA Biosciences, Inc. (IDYA) was 5,028,279 shares, as reported at the end of Q2 2025.